Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer

US Patent 9725447 · Granted Aug 8, 2017

Assignee

Inventors

View full patent text on Google Patents →